Company news
Ventripoint Diagnostics Ltd. (TSXV:VPT) news
Ventripoint Diagnostics Ltd. news releases on 6ix. Latest, Sep 17, 2024: Ventripoint Announces Filing Amended and Restated Offering Document for Non-Brokered…
Press releases — page 3
Ventripoint Announces Filing Amended and Restated Offering Document for Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
September 17, 2024
Ventripoint to Launch Reference Site Programme to Deepen Collaborations with Hospital Partners
September 9, 2024
Ventripoint Hires ERG to Provide Investor Relations Services
September 9, 2024
Ventripoint Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
August 29, 2024
Ventripoint Provides Financing Update
August 28, 2024
Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology
August 21, 2024
Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to Health Canada for Medical Device License
August 12, 2024
Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering
July 2, 2024
Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect
June 24, 2024
Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
June 13, 2024
Ventripoint Diagnostics Announces Shareholder Update and Teleconference
June 11, 2024
Ventripoint Applies for Extension of Non-Brokered Convertible Debenture Private Placement
May 14, 2024
Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration
May 6, 2024
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology
May 1, 2024
Ventripoint Announces Non-Brokered Convertible Debenture Private Placement
April 11, 2024
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
March 28, 2024
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use
March 4, 2024
Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences
February 20, 2024
Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales
February 13, 2024
Ventripoint Announces Changes to The Board of Directors
February 13, 2024
Ventripoint Begins 2024 with Leadership Change
February 5, 2024
The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System
February 1, 2024
The 2023 Year in Review
January 29, 2024
Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board
January 21, 2024
Ventripoint Whitepaper Distribution:
January 3, 2024
ASCEND Cardiovascular to Market and Distribute Ventripoint's AI-powered Heart-Scanning Technology to North American Hospitals and Clinics
December 12, 2023
Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals
December 5, 2023
Ventripoint Diagnostics Reports Third Quarter 2023 Financial Results
November 29, 2023
Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar
November 24, 2023
Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference
November 9, 2023
Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting
November 3, 2023
Ventripoint to Hold Annual General Meeting of Shareholders on November 1, 2023
October 24, 2023
Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference
October 12, 2023
Ventripoint Announces Appointment of Chief Finance Officer
October 3, 2023
Ventripoint's AI Heart Technology Takes Centre Stage In ITN Business "The Hidden Heart" Programme
September 28, 2023
Ventripoint to Sponsor DGPK Echo Advanced Workshop
September 15, 2023
Ventripoint to Sponsor 51st Annual Nordic Paediatric Cardiology Meeting
September 13, 2023
Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium
September 8, 2023
Ventripoint Diagnostics Reports Second Quarter 2023 Financial Results
August 30, 2023
Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar
August 25, 2023
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
August 22, 2023
Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular
August 18, 2023
Ventripoint Announces Collaboration with Ascend Cardiovascular
August 10, 2023
Ventripoint Diagnostics to Attend 8th World Congress of Paediatric Cardiology and Cardiac Surgery
August 2, 2023
Ventripoint's VMS+ Purchased by Medical Center - University of Freiburg
July 18, 2023
Ventripoint to Sponsor Advanced Imaging 2023 in London, England
July 11, 2023
Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany
July 5, 2023
Ventripoint Receives European Union Medical Device Regulation Certification
May 30, 2023
Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results
May 29, 2023
Ventripoint Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
May 2, 2023